Cancer Weekly articles from September 2002

Cancer Weekly archives from September 2002

18F-FDG PET predicts treatment outcome.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- A new and somewhat controversial study published in the August 2002 issue of the Journal of Nuclear Medicine suggests that 18F-FDG PET results obtained after the first cycle of treatment can better...

New research supports the link between cooking and carcinogens.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- French fries and potato chips may be doing more than just clogging our arteries and padding our guts. The first peer-reviewed study of acrylamide levels in foods suggests the suspected carcinogen forms...

Findings support shorter course of radiation therapy after lumpectomy.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- A shorter, more convenient course of radiation therapy after breast lumpectomy appears to be just as effective as the longer, more standard, regimen, according to new research appearing in the August 7,...

Investigators use guilt-by-association strategy to track potential cancer-causing genes.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- A detective has a slim chance of catching a crook who escapes without a trace. But an investigator who can track a culprit's friends and associates might learn much about a criminal's next target. ...

Race makes difference for value of alpha-fetoprotein as cancer marker.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Researchers at Stanford University School of Medicine say alpha-fetoprotein is not as useful a marker for primary liver cancer in African-Americans with chronic...

Amplified genome area mapped; new gene is overexpressed in oral cancer.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Investigators from the University of Pittsburgh have used a new technique to map a region of the genome - chromosomal band 11q13 - that is present in extra copies, or amplified, in a large percentage of...

American Cancer Society CEO elected president of International Union Against Cancer.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- The CEO of the American Cancer Society, the nation's leading voluntary health organization, has assumed an additional role as volunteer president of the International Union Against Cancer (Union...

New cancer target may hold promise in treating lymphoma and leukemia.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- At the 31st annual meeting of the International Society for Experimental Hematology held in Montreal, Canada, scientists from Cell Therapeutics, Inc., (CTIC) presented preclinical results that examined...

Drugs typically used in later stages find a market in early stages as well.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announced that breast cancer drugs typically used in later stages of the disease will...

Obesity might play part in increasing breast cancer rates among Hispanics.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Hispanic women have been known to run a lower risk of developing breast cancer than most other women, but their breast cancer rates are climbing - and increasing obesity is one factor that might be to...

U.S. study shows no link to pollution.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- A study on possible links between pollution and the high rates of breast cancer on Long Island failed to show a connection. Results of the 7-year, $8 million, study by the National Cancer...

MediGene receives patents treatment with oncolytic herpes simplex viruses.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- The German-American biopharmaceutical company MediGene AG (MDG) announced that the U.S. Patent and Trademark Office has issued two patents (6,340,673 and 6,379,674) that are exclusively licensed to...

U.K. researchers announce positive results for gene-based therapeutic vaccine.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Oxford BioMedica, plc, has released date from phase I/II clinical trial of TroVax, a gene-based therapeutic vaccine for the treatment of colorectal cancer. The data, presented at the International...

YKL-40 a possible marker for tumor grade and burden in deadly brain cancer.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - New genetic detection techniques have enabled medical investigators to discover the gene for a protein that may be a serum marker for glioblastoma multiforme,...

Gene transfer lessens cisplatin-induced damage to auditory system.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Gene therapy administered prior to the induction of cisplatin chemotherapy might alleviate the potential for hearing loss in some cancer patients. It also...

New screening test may help predict relapse.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- A new screening test to be piloted in Bristol could help to revolutionize the way children with leukemia are treated by enabling doctors to fine-tune treatment to the needs of each individual patient....

Breath test predicts postoperative health.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- For patients with lung cancer, surgical resection remains the best hope for cure. Desirable long-term goals of surgical resection include not only improvement in survival, but also quality of life. ...

British breadmaking wheats are selenium deficient.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Research just published has revealed selenium (Se) levels in British bread-making wheats are 10- to 50-fold lower than in their American or Canadian counterparts. Bread made from such wheat will fail...

Positive European opinion announced for OvaRex as orphan drug.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. announced that the Committee for Orphan Medical Products (COMP) of the European Agency for the Evaluation of Medicinal Products (EMEA) has adopted a positive opinion recommending the...

Specialization benefits women with advanced disease.(ovarian cancer)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- An estimated 23,300 new cases of ovarian cancer will be diagnosed in 2002, making it the fifth leading cause of cancer death among women in the U.S. For the majority of patients, ovarian cancer is...

Aspirin may help prevent pancreatic cancer.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Minnesota School of Public Health have found that aspirin use may decrease the incidence of pancreatic cancer, possibly through its anti-inflammatory effects. The study...

As cancer progresses, protein levels soar.(huntingtin interacting protein in prostate and colon cancer)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- A protein with an intriguing connection to the gene for Huntington disease could help physicians diagnose and more effectively treat patients with two of the most common and deadly forms of cancer,...

Payment issued for first Eligard launch.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced the company received $6 million from Sanofi-Synthelabo, Inc., related to the introduction of Eligard 7.5 mg, leuprolide acetate for injectable suspension,...

Zoladex significantly improves survival.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- New data published in the The Lancet show that the adjuvant use of Zoladex (goserelin acetate depot) with radiotherapy significantly prolongs overall survival, disease-free survival, and reduces disease...

Redirecting targets in kidney cancer would enable therapies to work better.
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Developing a different approach to tumor targeting may enhance the use of gene therapies directed towards renal cell carcinoma (RCC), research investigators...

Collaboration to focus on cancer biology research.(Brief Article)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Cellomics, Inc., announced that they have signed a collaborative agreement with the University of California, San Francisco (UCSF) Comprehensive Cancer Center. UCSF will implement Cellomics' High...

New treatment evaluated.(for skin cancer and actinic keratosis)
September 3, 2002... 2002 SEP 3 - (NewsRx.com & NewsRx.net) -- Roswell Park Cancer Institute (RPCI) has initiated two Phase II clinical trials to evaluate the safety and effectiveness of photodynamic therapy (PDT) using a newly developed topical photosensitizing...

Drug provides important option for patients with advanced disease.(colorectal cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- The approval of a new drug for advanced colorectal cancer provides an important new option for patients whose disease has defied other therapies, said the Vanderbilt-Ingram Cancer Center investigator...

Pulsing patient's cells with tumor antigen could be effective cancer vaccine.(liver cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using a patient's own immune response cells and antigens from tumor cells could be the best way to treat some patients with primary liver cancer. Newer...

Physician practice outcomes measured.(breast cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- A surprising number of variations exist in the way physicians diagnose and treat mammogram-detected breast cancer, according to a study published in the August 2002 issue of Cancer. Researchers...

Tumor suppressor protein p27Kip1 arrests development in renal cell carcinoma.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Gene therapy encoded for the tumor suppressor protein p27Kip1 might be an effective treatment for renal cell carcinoma. Adrienne L. Katner and colleagues...

ADA outlines risk factors.(American Dental Association, oral cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Most participants in a large East Coast study demonstrated a lack of knowledge about oral cancer risk factors, awareness of oral cancer examinations and the importance of early detection, according to...

New virus may be prognostic marker for chronic hepatitis C-related liver cancer.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - TT virus, also known as transfusion transmitted virus, may be a marker for cancer progression in people with chronic hepatitis C-related liver disease. TT...

Multimodal approach best for treating some breast cancers.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Doctors in Germany have prescribed a multilevel approach for banishing the expression of proteins that contribute to breast cancer pathogenesis. Treatment...

Study: Bisphosphonates don't impair skeletal uptake of Quadramet.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Cytogen Corp. (CYTO) reported that a new study shows that the use of bisphosphonates to treat breast cancer patients with bone metastasis does not adversely affect the skeletal uptake of Quadramet, a...

Study identifies upregulated enzyme in invasive breast cancers.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Sonia Bell-Nichols, senior medical writer - Upregulated expression of an extracellular enzyme seems be responsible for the invasiveness of breast cancers. Diminishing its activity at the molecular...

Researchers use antisense technology to delete mutant cells.(Brief Article)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- The ideal cancer drug wipes out tumor cells leaving healthy cells intact - but few achieve such an aim. Now, researchers at the Hebrew University in Jerusalem have devised a strategy to better target...

Scientists find genetic pathway to potent anticancer agents.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Exploring the genomes of two different but related soil microbes, scientists from the University of Wisconsin-Madison have found the genes that govern the production of a class of highly potent...

RNA interference silences cancer genes in leukemia cells.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A technique that uses bits of double-stranded RNA to silence human genes could be used for treating cancer cells containing mutated genes, researchers in...

Gleevec's effectiveness on untreatable cancer shown.(gastrointestinal cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Researchers are confident they have proved that a deadly, untreatable gastrointestinal cancer is triggered by one protein that can be stopped with the drug Gleevec. More than half of patients...

Hepatitis C, Epstein-Barr virus interactions have little impact on lymphoma risk.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Interactions between hepatitis C and Epstein-Barr viruses have little effect on the risk of non-Hodgkin lymphoma in HIV patients, researchers in France argue....

Low-dose paclitaxel effective for high-risk Kaposi sarcoma patients.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Paclitaxel therapy can help patients suffering from refractory Kaposi sarcoma, according to researchers in the United States. "Treatment options are...

Injectable gel effective treatment.(head and neck cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- An injectable gel combining cisplatin and epinephrine is effective in treating cancers of the head and neck, according to a new study published in the Archives of Otolaryngology and Head and Neck...

Human herpesvirus-8 infection common in south Texas children.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Young children in south Texas have a surprisingly high risk of infection with a cancer-causing virus, researchers warn. "Human herpesvirus 8 (HHV-8), also...

New markers to be developed for use with CA125II.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Fujirebio Diagnostics, Inc., (FDI), a leading oncology diagnostics company, announced that it has acquired the rights from Pacific Northwest Research Institute (PNRI) to develop two newly discovered...

Study suggests carboplatin could be first-line chemotherapy.(ovarian cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Results of an international study in the August 17, 2002, issue of the Lancet suggest that the drug carboplatin could become a first-line chemotherapeutic agent for the treatment of ovarian cancer....

FDA approves Eligard 22.5 mg.
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for Eligard 22.5 mg (leuprolide acetate for injectable suspension),...

Innovative microsurgery reduces risk of incontinence, impotence.(prostate cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Doctors at Jersey Shore Medical Center in Neptune, New Jersey, are among the first in the country to use an innovative new procedure to reduce or eliminate unwanted side effects of prostate removal....

Study shows potency improvement rates in patients treated with cryosurgery.(prostate cancer)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- Endocare, Inc., (ENDO), a developer of diagnostic and treatment tools for cancer and other diseases, announced that a peer-reviewed study published in the journal Urology demonstrates that the new...

ILEX initiates phase I Clofarex study.(ILEX Oncology Inc.)
September 10, 2002... 2002 SEP 10 - (NewsRx.com & NewsRx.net) -- ILEX Oncology, Inc., (ILXO) has initiated phase I clinical trial to evaluate the investigational anticancer agent Clofarex (clofarabine) in adults with advanced solid tumors. This is the first...

Technique to induce cancer cells to 'commit suicide' developed by Hebrew University scientists.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- A new technique for tricking cancer cells into "committing suicide" and thus preventing their spread has been developed by researchers at the Hebrew University of Jerusalem. Their work is described in...

Measles, varicella, and influenza immunizations recommended for adult cancer patients.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Cancer patients face a high risk of morbidity and mortality from measles, influenza, and varicella and should be immunized to protect against these...

Reactive nitrogen species foster vascularity of breast tumors.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A marker for protein conversion has been used to detect reactive nitrogen species at the edges of breast cancer tumors. These nitric oxide derivatives may...

Anti-inflammatory drug reduces growth of cancerous tumors in rats.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- Research led by a nurse investigator at Johns Hopkins has found that a pain reliever commonly used to treat serious and painful forms of arthritis may also reduce the growth of malignant tumors after...

New drug possible from compound found in common food.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- A compound found in many foods and drinks could form the basis for new drugs to defeat cancer and heart disease, scientists at University College London (UCL) claim. Professor Peter Shepherd and...

Cancer patients can be endangered by CAM 'cures' on the web.(complementary and alternative medicine)
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- Internet websites promoting "alternative" cures for cancer can seriously harm patients who follow their advice. And some are downright dangerous - according to an editorial published in the British...

Novel gene product facilitates suicide gene tracking in male cancers.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Medical researchers at the University of California School of Medicine in Los Angeles have discovered a novel gene product that enables doctors to track...

Radiation therapy alone is therapeutic.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- Radiation therapy alone is an adequate treatment for some patients with rectal cancer, according to the September 2002 issue of the International Journal of Radiation Oncology, Biology and Physics, the...

Drug reduces transfusions and chemotherapy-related fatigue.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- Patients treated with darbepoetin alfa (Aranesp) for chemotherapy-induced anemia may require fewer blood transfusions and feel less fatigued than patients receiving a placebo, concludes a new study in...

New broccoli compound appears promising.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- In the future, a "broccoli pill" a day may help keep breast cancer at bay. Researchers have developed a new compound, designed from a known anticancer agent found in broccoli, that shows promise as a...

Risk from susceptibility gene may be exaggerated in most studies.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- An analysis of past studies on mutations in the breast cancer susceptibility genes BRCA1 and BRCA2 suggests that estimates of penetrance (or the likelihood that mutation carriers will develop breast...

Zadaxin increases survival rate in NIH animal model.(National Institutes of Health)(Brief Article)
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- SciClone Pharmaceuticals (SCLN) announced the positive results of a breast cancer animal model study using monotherapy Zadaxin as an immune system enhancer. At the 21-week endpoint of the study,...

Blocking pathway overcomes tumor vessel resistance to radiation.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- Blocking a specific signaling pathway with drugs can make blood vessels more susceptible to the effects of radiation and improve tumor control, Vanderbilt-Ingram Cancer Center scientists have...

Gene for common cold makes cancer cells susceptible to therapeutic attack.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- A researcher at the University of Illinois at Chicago College of Medicine is discovering how a gene known as E1A, found in a virus responsible for the common cold, renders tumor cells vulnerable to...

New agent arrests vessel formation in ovarian and breast cancers.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new agent developed by researchers at Lilly Research Laboratories can knock down ovarian and breast cancer growth. The agent, known as 317615.2HC1,...

Vaccine that targets human chorionic gonadotropin extends colorectal cancer patient survival.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Inoculation with a vaccine that generated an antibody response against human chorionic gonadotropin (hCG) increased survival of patients with...

Positive results of studies released for Ursodiol.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., announced positive final statistical analysis of a phase II study assessing the efficacy of URSO 250 in the prevention of the recurrence of colorectal adenomatous polyps as well as...

September 3, 2002 issue.(Correction Notice)
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- NewsRx was notified that the press release for the article "Breath test predicts postoperative health," (Sept. 3, 2002) contained an error. The third paragraph should read: A measurement for...

Lack of social support reinforces tumor factor in women with ovarian cancer.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical - The lack of sufficient social support may cause some women with ovarian cancer to produce abnormal levels of a growth factor that spurs cancer growth. Doctors...

Growing hepatitis C infection rate associated with primary liver cancer.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The growing hepatitis C virus (HCV) infection rate in the United States appears to be causing an increasing incidence of hepatocellular carcinoma HCC, a...

Mumps vaccine induces remission in patients with recurrent respiratory papilloma.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Combining laser excision of recurring respiratory papilloma tumors with injection of mumps vaccine into the excision site increased remission rate of...

Second phase I study of huN901-DM1/BB-10901 initiated.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- ImmunoGen, Inc., (IMGN) and British Biotech plc announced that patient treatment has begun in the planned second phase I study of huN901-DM1/BB- 10901, a novel anticancer agent targeted at small-cell...

European Commission grants orphan drug designation in for OvaRex MAb.(Brief Article)
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. confirmed that the European Commission has granted orphan medicinal product designation for OvaRex MAb (Oregovomab) for the treatment of ovarian cancer. Orphan drug designation makes...

Gene therapy may enhance effectiveness of chemotherapeutic agents.
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC), a biopharmaceutical company developing gene-based medicines, announced that a scientific paper, "Transcriptional Control of Viral Gene Therapy by Cisplatin" by Weichselbaum et al,...

Casodex reduces disease, tumor progression.(Brief Article)
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- The first major publication of the overall results from the world's largest prostate cancer treatment program shows that addition of Casodex (bicalutamide) to standard care cuts the risk of tumor...

Dietary change may prevent disease progression.(prostate cancer)
September 17, 2002... 2002 SEP 17 - (NewsRx.com & NewsRx.net) -- A fat-laden diet and high calcium consumption are both well-known suspected risk factors for prostate cancer. However, new findings from the Fred Hutchinson Cancer Research Center suggest that fat...

Antiangiogenic affect of purine analogs may help in hematological cancers.
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Data collected in a new study has made researchers suspect that purine analogs used for treating acute myelogenous or myeloid leukemia (AML) may have...

Intensive vaccine reinduction extends survival for melanoma patients.
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Intensive vaccine reinduction therapy for patients with recurrent malignant melanoma significantly increased survival time, according to researchers...

Discovery sheds light on how cells progress to more aggressive forms.(of breast cancer)
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- Despite recent advances in breast cancer treatment that have led to long-term survival for millions of women, most tumors eventually stop responding to standard therapies. The result is a poor...

Gene therapy boosts cancer treatment.
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Chicago have found a way to combine cancer chemotherapy with gene therapy designed to disrupt the growth of blood vessels to a tumor. The combination, tested in mice,...

Researchers find gene that causes leukemia in children.
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- Researchers from the University of Chicago have identified a gene defect that causes the development of leukemia in children with Down syndrome. The discovery, published on Nature Genetics' web site,...

Major NCI study finds increased risk of cancer in long-term survivors.(National Cancer Institute)
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- An international study of more than 32,000 Hodgkin disease patients has shown that long-term survivors of the disease have double the normal risk of developing a subsequent cancer later in life. ...

New drug boost for asbestos-related sufferers.(pemetrexed for the treatment of mesothelioma)
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- Clinical trials of a new anticancer drug combination carried out by researchers at Newcastle University show that it has potential to almost double the life expectancy of sufferers of mesothelioma - a...

Viragen and University of Miami form anticancer project.
September 24, 2002... 2002 SEP 24 - (NewsRx.com & NewsRx.net) -- Viragen, Inc., (VRA) and the University of Miami's office of technology transfer announced that they have entered into an agreement to develop anticancer technology. The joint project is designed...